Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Starpharma Holdings Limited ABN/ARBN Financial year ended: 20 078 532 180 30 June...
2026 Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- 2026 Annual Report
- Preliminary Final Report
- Becoming a substantial holder
- Ceasing to be a substantial holder
- Change in substantial holding
Later from Starpharma
- FY26 Key Financial Results and Annual Report
- S&P DJI Announces September 2026 Quarterly Rebalance
- Annual General Meeting 2026 Date
- Chair and Deputy Chair Appointments
- Notification of cessation of securities - SPL
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma